OACCW — Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Company profile
- Sector: Financial Services
- Industry: Shell Companies
- Country: US
- Exchange: NASDAQ
- Website: https://www.oaktreeacquisitioncorp.com/oac-iii
Latest SEC filings for OACCW
- 4 — 2026-10-23
- SCHEDULE 13G — 2026-08-14
- SCHEDULE 13G — 2026-08-13
- SCHEDULE 13G — 2026-05-15
- SCHEDULE 13G — 2026-05-11
Educational tool only — not investment advice.